A Much-Anticipated Leap Forward in β-Lactam Drug Allergy: Phenotyping Reactions to Piperacillin/Tazobactam

J Allergy Clin Immunol Pract. 2020 Oct;8(9):3178-3179. doi: 10.1016/j.jaip.2020.05.013.

Authors

Ricardo Madrigal-Burgaleta¹, Bryan Fernandes², Danie Watson³, Nadia Shafi³, Fawzia Runa Ali²

Affiliations

¹ Allergy & Severe Asthma Service, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom. Electronic address: ricardo.madrigal.md.phd@gmail.com.
² Allergy & Severe Asthma Service, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
³ Adult Cystic Fibrosis Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.

PMID: 33039017
DOI: 10.1016/j.jaip.2020.05.013

No abstract available

Publication types

Editorial
Comment

MeSH terms

Drug Hypersensitivity* / diagnosis
Humans
Phenotype
Piperacillin
Piperacillin, Tazobactam Drug Combination
beta-Lactams* / adverse effects

Substances

beta-Lactams
Piperacillin, Tazobactam Drug Combination
Piperacillin